X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14) 14
cancer (13) 13
humans (13) 13
mutation (10) 10
life sciences (8) 8
female (6) 6
aged (5) 5
hematology (5) 5
male (5) 5
pathology (5) 5
[sdv.can]life sciences [q-bio]/cancer (4) 4
biomarkers, tumor - genetics (4) 4
genetic aspects (4) 4
middle aged (4) 4
[ sdv.can ] life sciences [q-bio]/cancer (3) 3
[ sdv.mhep.hem ] life sciences [q-bio]/human health and pathology/hematology (3) 3
bile duct neoplasms - genetics (3) 3
bile duct neoplasms - pathology (3) 3
biomarkers (3) 3
cell biology (3) 3
cell line, tumor (3) 3
cholangiocarcinoma (3) 3
deoxyribonucleic acid--dna (3) 3
ebv (3) 3
gene mutations (3) 3
human health and pathology (3) 3
lymphomas (3) 3
polymerase chain reaction (3) 3
rhoa (3) 3
tumors (3) 3
adenoma, bile duct - genetics (2) 2
adenoma, bile duct - pathology (2) 2
adult (2) 2
aged, 80 and over (2) 2
aitl (2) 2
animals (2) 2
apoptosis (2) 2
apoptosis - drug effects (2) 2
autophagy (2) 2
becn1 (2) 2
bile ducts, intrahepatic - pathology (2) 2
biomarkers, tumor (2) 2
blockade (2) 2
burkitt lymphoma (2) 2
carcinoma (2) 2
care and treatment (2) 2
colorectal cancer (2) 2
colorectal neoplasms - genetics (2) 2
differentiation (2) 2
drug therapy (2) 2
features (2) 2
genes (2) 2
hamartoma (2) 2
hamartoma - pathology (2) 2
hemic and lymphatic diseases (2) 2
immunohistochemistry (2) 2
immunotherapy (2) 2
isocitrate dehydrogenase - genetics (2) 2
isocitrate dehydrogenase mutations (2) 2
leukemia (2) 2
lymphoma (2) 2
lymphoma, b-cell - genetics (2) 2
mediastinal neoplasms - genetics (2) 2
metastasis (2) 2
nulin-3 (2) 2
oncology (2) 2
pd-1 (2) 2
phosphorylation (2) 2
proto-oncogene proteins b-raf - genetics (2) 2
resistance (2) 2
studies (2) 2
tet2 (2) 2
tp53 (2) 2
young adult (2) 2
2-hydroxyglutarate (1) 1
[chim.orga]chemical sciences/organic chemistry (1) 1
[sdv.mhep.hem]life sciences [q-bio]/human health and pathology/hematology (1) 1
[sdv:sa] life sciences/agricultural sciences (1) 1
abt-737 (1) 1
acrylates - pharmacology (1) 1
activation (1) 1
active transport, cell nucleus - drug effects (1) 1
acute myeloid-leukemia (1) 1
acvbp plus rituximab (1) 1
adaptor proteins, signal transducing (1) 1
adaptor proteins, signal transducing - genetics (1) 1
adolescent (1) 1
angioimmunoblastic t-cell lymphoma (1) 1
animals; biomarkers, tumor; flow cytometry; gene expression regulation, neoplastic; genotype; glutarates/metabolism; humans; isocitrate dehydrogenase/genetics; isocitrate dehydrogenase/metabolism; leukemia, myeloid, acute/genetics; leukemia, myeloid, acute/metabolism; lymphocytes/metabolism; lymphoma, t-cell/immunology; lymphoma, t-cell/metabolism; mice; mice, knockout; mutation; 2-hydroxyglutarate; aitl; t cell; isocitrate dehydrogenase; lymphoma (1) 1
anti-pd-l1 antibody (1) 1
apoptose (1) 1
autophagie (1) 1
autophagy - drug effects (1) 1
b-lymphocytes - cytology (1) 1
b-lymphocytes - virology (1) 1
b7-h1 antigen - biosynthesis (1) 1
b7-h1 antigen - genetics (1) 1
b7-h1 antigen - immunology (1) 1
basic research paper (1) 1
bcl-2 (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Translational Oncology, ISSN 1936-5233, 05/2019, Volume 12, Issue 5, pp. 784 - 787
Anaplastic lymphoma kinase ( ) rearrangement is reported in 3% to 8% of patients with lung adenocarcinoma and can be detected by fluorescent hybridization... 
IN-SITU HYBRIDIZATION | FISH | LUNG-CANCER | NSCLC | ONCOLOGY
Journal Article
The Journal of molecular diagnostics : JMD, ISSN 1525-1578, 09/2018, Volume 20, Issue 5, pp. 677 - 685
Angioimmunoblastic T-cell lymphoma (AITL) is a peripheral T-cell lymphoma associated with chemoresistance and a poor prognosis. Various nonsynonymous mutations... 
Life Sciences | Cancer
Journal Article
Lung Cancer, ISSN 0169-5002, 11/2019, Volume 137, pp. 149 - 156
The understanding of histo-molecular mechanisms associated with resistance to osimertinib is a critical step to define the optimal treatment strategy in... 
Resistance | Osimertinib | C797S | MET | EGFR | Non-small cell lung cancer
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 11/2014, Volume 24, Issue 21, pp. 5086 - 5088
Journal Article
European Respiratory Journal, ISSN 0903-1936, 09/2016, Volume 48, Issue suppl 60, p. PA2834
Journal Article
Clinical Chemistry, ISSN 0009-9147, 08/2016, Volume 62, Issue 8, pp. 1129 - 1139
Journal Article
Haematologica, ISSN 0390-6078, 09/2019, p. haematol.2019.226647
Peripheral T-cell lymphoma comprises a heterogeneous group of mature non-Hodgkin lymphomas. Their diagnosis is challenging, with up to 30% of cases remaining... 
Journal Article
Hepatology, ISSN 0270-9139, 01/2015, Volume 61, Issue 1, pp. 403 - 405
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 2017, Volume 41, Issue 12, pp. 1581 - 1592
Skin biopsies of 41 angioimmunoblastic T-cell lymphoma patients were retrospectively analyzed for the expression of follicular helper T-cell (TFH) markers,... 
mutation | TFH markers | IDH2 | angioimmunoblastic T-cell lymphoma | cutaneous localization | RHOA G17V | RHOA | DERIVATION | SURGERY | FREQUENT | INVOLVEMENT | TET2 | MYCOSIS-FUNGOIDES | PATHOLOGY | CXCL13 | FEATURES | PD-1 | AITL | Immunohistochemistry | Lymphoma, T-Cell, Cutaneous - immunology | Humans | Programmed Cell Death 1 Receptor - analysis | Chemokine CXCL13 - analysis | rhoA GTP-Binding Protein - genetics | DNA Mutational Analysis - methods | Lymphoma, T-Cell, Cutaneous - genetics | Herpesvirus 4, Human - isolation & purification | Skin Neoplasms - enzymology | T-Lymphocytes, Helper-Inducer - immunology | T-Lymphocytes, Helper-Inducer - enzymology | Polymerase Chain Reaction | Immunoblastic Lymphadenopathy - pathology | T-Lymphocytes, Helper-Inducer - pathology | Skin Neoplasms - pathology | Genetic Predisposition to Disease | Skin Neoplasms - immunology | Biomarkers, Tumor - analysis | Immunoblastic Lymphadenopathy - genetics | Neprilysin - analysis | Isocitrate Dehydrogenase - genetics | Immunoblastic Lymphadenopathy - enzymology | Inducible T-Cell Co-Stimulator Protein - analysis | Lymphoma, T-Cell, Cutaneous - pathology | Lymphoma, T-Cell, Cutaneous - enzymology | Phenotype | Skin Neoplasms - genetics | Biomarkers, Tumor - genetics | Mutation | Immunoblastic Lymphadenopathy - immunology | Life Sciences | Cancer
Journal Article
Blood and Lymphatic Cancer: Targets and Therapy, ISSN 1179-9889, 01/2015, Volume 5, Issue default, pp. 93 - 100
The tumor suppressor TP53 is frequently mutated or inactivated in human cancers. Mutations of TP53 are less common in lymphomas than in other tumors, but the... 
Care and treatment | Non-Hodgkin's lymphomas | Tumor proteins | Drug therapy | T cells | Cancer | Enzymes | Phosphorylation | Hematology | Leukemia | DNA damage | Cyclin-dependent kinases | Genes | Kinases | Studies | Cell cycle | Lymphomas | Mutation | Deoxyribonucleic acid--DNA | Apoptosis
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.